Literature DB >> 31612009

Plasma desacyl ghrelin-to-acyl ghrelin ratio is a predictor of postoperative complications and prognosis after pancreaticoduodenectomy.

Takahiro Nishida1, Hironobu Tsubouchi2, Takeomi Hamada3, Naoya Imamura3, Masahide Hiyoshi3, Koichi Yano3, Kenji Kangawa4, Masamitsu Nakazato2, Atsushi Nanashima3.   

Abstract

The current study aimed to clarify the significance of the preoperative desacyl ghrelin (DG)-to-acyl ghrelin (AG) ratio in patients undergoing pancreaticoduodenectomy (PD). Ghrelin, a peptide hormone mainly produced in the stomach, possesses unique functions. Recently, studies have determined the involvement of plasma gherlin in certain postoperative outcomes, particularly in surgical resections of the stomach. Although PD involves gastric resection, few reports have determined the involvement of ghrelin following PD. From April 2003 to December 2011, 195 patients underwent PD for tumors of the pancreatic head, bile duct and ampulla of Vater at the Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine (Miyazaki, Japan). Of these, 83 patients were enrolled into the present study as their plasma gherlin levels were measured. AG, DG, total ghrelin (TG) and the DG-to-AG ratio (D/A) were subsequently assessed. Furthermore, the prognostic nutritional index (PNI) and high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) were determined. Morbidity was examined in all 83 patients, but mortality was only determined in 69 individuals after 14 patients were excluded due to the presence of benign disease. The results revealed that the TG of patients undergoing standard PD (SPD) was significantly lower than that of patients undergoing pylorus-preserving PD or subtotal stomach-preserving PD. It was also determined that TG levels declined significantly in SPD patients at 2 weeks after surgery. Negative associations were identified between plasma ghrelin levels and PNI, and between serum albumin and HS-mGPS. Patient morbidity was determined to be 31.3% and the severe complications exhibited by patients included pancreatic fistula (14.5%), intra-abdominal abscess (15.7%), intra-abdominal bleeding (6.0%) and liver abscess (1.2%). Multivariate analysis revealed that disease location and low D/A were independent risk factors for severe complications. The 5-year overall survival (OS) rate was 41.5%. Multivariate analysis also demonstrated that diabetes mellitus, long postoperative hospital stay and low D/A were independent risk factors for OS. The present study revealed the D/A may serve as a useful predictive factor for postoperative complications and prognosis after PD.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  acyl ghrelin; desacyl ghrelin; desacyl ghrelin-to-acyl ghrelin ratio; pancreaticoduodenectomy; prognosis

Year:  2019        PMID: 31612009      PMCID: PMC6781775          DOI: 10.3892/ol.2019.10821

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

1.  Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.

Authors:  A Asakawa; A Inui; T Kaga; H Yuzuriha; T Nagata; N Ueno; S Makino; M Fujimiya; A Niijima; M A Fujino; M Kasuga
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

2.  Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy.

Authors:  Ko Takachi; Yuichiro Doki; Osamu Ishikawa; Isao Miyashiro; Yo Sasaki; Hiroaki Ohigashi; Kohei Murata; Hiromu Nakajima; Hiroshi Hosoda; Kenji Kangawa; Fujiko Sasakuma; Shingi Imaoka
Journal:  J Surg Res       Date:  2005-09-22       Impact factor: 2.192

3.  Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.

Authors:  Tomomi Shiiya; Masamitsu Nakazato; Masanari Mizuta; Yukari Date; Muhtashan S Mondal; Muneki Tanaka; Shin-Ichi Nozoe; Hiroshi Hosoda; Kenji Kangawa; Shigeru Matsukura
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

Review 4.  Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.

Authors:  I Ozola Zalite; R Zykus; M Francisco Gonzalez; F Saygili; A Pukitis; S Gaujoux; R M Charnley; V Lyadov
Journal:  Pancreatology       Date:  2014-12-04       Impact factor: 3.996

Review 5.  Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy.

Authors:  Shuji Takiguchi; Akihiro Takata; Kohei Murakami; Yasuhiro Miyazaki; Yoshitomo Yanagimoto; Yukinori Kurokawa; Tsuyoshi Takahashi; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2013-09-20       Impact factor: 7.370

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients.

Authors:  Yuichiro Yano; Masamitsu Nakazato; Koji Toshinai; Takashi Inokuchi; Shuntaro Matsuda; Toshiaki Hidaka; Manabu Hayakawa; Kenji Kangawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2013-12-21       Impact factor: 2.689

8.  Adipokines and ghrelin in gastric cancer cachexia.

Authors:  Mustafa Kerem; Zafer Ferahkose; Utku Tonguc Yilmaz; Hatice Pasaoglu; Ebru Ofluoglu; Abdulkadir Bedirli; Bulent Salman; Tevfik Tolga Sahin; Murat Akin
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

9.  The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy.

Authors:  Peng Zhang; Mian Xi; Qiao-Qiao Li; Li-Ru He; Shi-Liang Liu; Lei Zhao; Jing-Xian Shen; Meng-Zhong Liu
Journal:  J Cancer       Date:  2014-09-06       Impact factor: 4.207

10.  High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy.

Authors:  Peng Chen; Min Fang; Qiuyan Wan; Xuebang Zhang; Tao Song; Shixiu Wu
Journal:  Oncotarget       Date:  2017-10-11
View more
  2 in total

1.  Gut peptide changes in patients with obstructive jaundice undergoing biliary drainage: A prospective case control study.

Authors:  Tajana Pavić; Stipe Pelajić; Nina Blažević; Dominik Kralj; Milan Milošević; Ivana Mikolasevic; Ivan Lerotic; Davor Hrabar
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

2.  Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer.

Authors:  Masayuki Tomioka; Tohru Yoneyama; Yuki Tobisawa; Kota Kawase; Chie Nakai; Manabu Takai; Daiki Kato; Koji Iinuma; Keita Nakane; Kosuke Mizutani; Yasuhiro Hashimoto; Takuya Koie
Journal:  Transl Androl Urol       Date:  2021-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.